Healthcare Business

Is Spectrum Pharma Getting Enough for Its Hematology/Oncology Portfolio?

Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI) shares made a handy gain early Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products to Acrotech ...
Read Full Story »

Where Does Aptinyx Go Next After Disappointing Midstage Results for Pain Treatment?

Aptinyx Inc. (NASDAQ: APTX) shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with painful diabetic peripheral neuropathy (DPN). Specifically, Aptinyx ...
Read Full Story »

Why CVS and Walmart Are Parting Ways

CVS Health Corp. (NYSE: CVS) has announced that it will be parting ways with megastore Walmart Inc. (NYSE: WMT). Specifically, Walmart has opted to leave the CVS Caremark pharmacy benefit management ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, December 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Why the FDA Is Coming Down on Akorn

Akorn Inc. (NASDAQ: AKRX) shares dipped on Wednesday after the company received a warning letter from the U.S. Food and Drug Administration (FDA). The letter is in relation to an ...
Read Full Story »

Moderna Makes Big Post-IPO Strides With Pipeline Update

Moderna Inc. (NASDAQ: MRNA) shares made a handy gain early Tuesday after the company announced updates to several of its immuno-oncology and rare disease programs and outlined its 2019–2020 corporate ...
Read Full Story »

Alector Files for IPO

Alector has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). No pricing details were given in the filing, although the ...
Read Full Story »

Are Loxo Shareholders Getting Enough in the Buyout?

Loxo Oncology Inc. (NASDAQ: LOXO) shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly and Co. (NYSE: LLY). The ...
Read Full Story »

Why Axsome Therapeutics Depression Study Is All Smiles

Axsome Therapeutics Inc. (NASDAQ: AXSM) shares absolutely exploded on Monday after the company announced that its midstage trial in patients with major depressive disorder (MDD) met its primary endpoint. Not ...
Read Full Story »

Poseida Therapeutics Gears Up for IPO

Poseida Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although ...
Read Full Story »

Major Biopharma Catalysts Coming in the First Quarter of 2019

Biotech and pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Ultragenyx Wins Big in Blood Sugar Study

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen ...
Read Full Story »

6 Top Health Care Picks Set to Scream Higher in 2019

With all the stock market volatility at the end of 2018, many investors have been scratching their heads and wondering how they want their assets and portfolios to be positioned ...
Read Full Story »

Will the Selecta Biosciences Restructuring Pay Off?

Selecta Biosciences Inc. (NASDAQ: SELB) shares pushed higher on Friday after the company provided an update on its new streamlined structure under its new president and chief executive officer. In ...
Read Full Story »